DISOPYRAMIDE PHARMACOKINETICS DURING RECOVERY FROM MYOCARDIAL-INFARCTION

被引:13
作者
BRYSON, SM [1 ]
CAIRNS, CJ [1 ]
WHITING, B [1 ]
机构
[1] STOBHILL GEN HOSP,DEPT PHARM,GLASGOW G21 3UW,SCOTLAND
关键词
D O I
10.1111/j.1365-2125.1982.tb01395.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:417 / 421
页数:5
相关论文
共 14 条
[1]   DISOPYRAMIDE SERUM AND PHARMACOLOGIC EFFECT KINETICS APPLIED TO ASSESSMENT OF BIOAVAILABILITY [J].
BRYSON, SM ;
WHITING, B ;
LAWRENCE, JR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) :409-419
[2]   RAPID GAS-CHROMATOGRAPHIC DETERMINATION OF DISOPYRAMIDE IN SERUM USING A NITROGEN DETECTOR [J].
DUCHATEAU, AMJA ;
MERKUS, FWHM ;
SCHOBBEN, F .
JOURNAL OF CHROMATOGRAPHY, 1975, 109 (02) :432-435
[3]   ABSORPTION, HALF-LIFE, AND TOXICITY OF ORAL APRINDINE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION [J].
HAGEMEIJER, F .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (01) :21-25
[4]   PROTEIN-BINDING AND ERYTHROCYTE PARTITIONING OF DISOPYRAMIDE AND ITS MONODEALKYLATED METABOLITE [J].
HINDERLING, PH ;
BRES, J ;
GARRETT, ER .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (11) :1684-1690
[5]   PHARMACOKINETICS OF ANTIARRHYTHMIC DISOPYRAMIDE IN HEALTHY HUMANS [J].
HINDERLING, PH ;
GARRETT, ER .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (03) :199-230
[6]  
ILETT KF, 1979, CLIN PHARMACOL THER, V26, P1
[7]  
KARIM A, 1975, ANGIOLOGY, V26, P85
[8]   PHARMACOKINETICS OF PROCAINAMIDE IN MAN [J].
KOCHWESER, J .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :370-+
[9]   PHARMACOKINETICS OF DISOPYRAMIDE IN PATIENTS WITH IMMINENT TO MODERATE CARDIAC-FAILURE [J].
LANDMARK, K ;
BREDESEN, JE ;
THAULOW, E ;
SIMONSEN, S ;
AMLIE, JP .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (03) :187-192
[10]  
MAWER G E, 1976, Clinical Pharmacokinetics, V1, P67, DOI 10.2165/00003088-197601010-00006